Track record

To date, HYPERION Life Sciences Ltd has mainly supported European, North-American and Latin American small & mid-sized companies from US$ 1 million up to US$10 billion annual turnover, willing to strengthen their activities in Europe and/or to expand their footprint in Emerging Markets

To receive information about our M&A and Licensing deals completed, please send enquiries

and meeting requests to info@hyperion-corpdev.com